| Literature DB >> 20613727 |
.
Abstract
A more transparent drug approval process has the potential to reduce cost and duplicated effort, as well as ultimately improve access to effective treatments for patients.Entities:
Mesh：
Year: 2010 PMID： 20613727 DOI： 10.1038/nm0710-723
Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440